SE470251B - Nya användningar av 4-(3-fosfono-2-propenyl)-2- piperazinkarboxylsyra - Google Patents

Nya användningar av 4-(3-fosfono-2-propenyl)-2- piperazinkarboxylsyra

Info

Publication number
SE470251B
SE470251B SE8900834A SE8900834A SE470251B SE 470251 B SE470251 B SE 470251B SE 8900834 A SE8900834 A SE 8900834A SE 8900834 A SE8900834 A SE 8900834A SE 470251 B SE470251 B SE 470251B
Authority
SE
Sweden
Prior art keywords
compound
formula
sleep
phosphono
propenyl
Prior art date
Application number
SE8900834A
Other languages
English (en)
Swedish (sv)
Other versions
SE8900834D0 (sv
SE8900834L (sv
Inventor
A K Dixon
J A Gray
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805875A external-priority patent/GB8805875D0/en
Priority claimed from GB888819192A external-priority patent/GB8819192D0/en
Priority claimed from GB888820344A external-priority patent/GB8820344D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8900834D0 publication Critical patent/SE8900834D0/xx
Publication of SE8900834L publication Critical patent/SE8900834L/
Publication of SE470251B publication Critical patent/SE470251B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8900834A 1988-03-11 1989-03-09 Nya användningar av 4-(3-fosfono-2-propenyl)-2- piperazinkarboxylsyra SE470251B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888805875A GB8805875D0 (en) 1988-03-11 1988-03-11 Improvements in/relating to organic compounds
GB888819192A GB8819192D0 (en) 1988-08-12 1988-08-12 Improvements in/relating organic compounds
GB888820344A GB8820344D0 (en) 1988-08-26 1988-08-26 Improvements in/relating to organic compounds

Publications (3)

Publication Number Publication Date
SE8900834D0 SE8900834D0 (sv) 1989-03-09
SE8900834L SE8900834L (sv) 1989-09-12
SE470251B true SE470251B (sv) 1993-12-20

Family

ID=27263823

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900834A SE470251B (sv) 1988-03-11 1989-03-09 Nya användningar av 4-(3-fosfono-2-propenyl)-2- piperazinkarboxylsyra

Country Status (15)

Country Link
US (1) US4939129A (it)
JP (1) JPH01279834A (it)
AU (1) AU618325B2 (it)
BE (1) BE1005178A3 (it)
CH (1) CH677611A5 (it)
DE (1) DE3907009A1 (it)
DK (1) DK118189A (it)
FR (1) FR2628322B1 (it)
GB (1) GB2216417B (it)
HU (1) HU202111B (it)
IT (1) IT1232818B (it)
MY (1) MY103844A (it)
NL (1) NL8900582A (it)
PT (1) PT89962B (it)
SE (1) SE470251B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
GB8703749D0 (en) * 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid

Also Published As

Publication number Publication date
AU3116489A (en) 1989-09-14
HUT52383A (en) 1990-07-28
FR2628322A1 (fr) 1989-09-15
IT1232818B (it) 1992-03-05
GB2216417B (en) 1991-12-11
JPH01279834A (ja) 1989-11-10
US4939129A (en) 1990-07-03
HU202111B (en) 1991-02-28
GB2216417A (en) 1989-10-11
FR2628322B1 (fr) 1994-09-09
DE3907009A1 (de) 1989-09-21
IT8947732A0 (it) 1989-03-10
DK118189A (da) 1989-09-12
NL8900582A (nl) 1989-10-02
PT89962A (pt) 1989-11-10
BE1005178A3 (fr) 1993-05-18
GB8905180D0 (en) 1989-04-19
DK118189D0 (da) 1989-03-10
SE8900834D0 (sv) 1989-03-09
MY103844A (en) 1993-09-30
PT89962B (pt) 1994-05-31
CH677611A5 (it) 1991-06-14
AU618325B2 (en) 1991-12-19
SE8900834L (sv) 1989-09-12

Similar Documents

Publication Publication Date Title
Abad et al. Immunomodulatory roles of PACAP and VIP: lessons from knockout mice
DE3587122T2 (de) Pharmakologisch aktive derivate von tryptophan und diese enthaltende pharmazeutische zusammensetzungen.
EA029999B1 (ru) Способы лечения аутизма
EP0490379A2 (de) Diaminosäurederivate und pharmazeutische Zusammensetzungen
TR201905098T4 (tr) Amyotrofik lateral sklerozun tedavi edilmesi ya da amyotrofik lateral skleroz fazının ilerleyişinin önlenmesi için farmasötik ajan
CZ355897A3 (cs) Způsob léčení mánie a bipolárních poruch
KR20090097943A (ko) 환상 포스파티딘산 유도체를 포함하는 진통제
JP2011207905A (ja) 脳虚血疾患を予防及び治療する薬剤の製造におけるｌ−ブチルフタリドの使用
US5376682A (en) Furanone derivatives for the treatment of inflammation
SE470251B (sv) Nya användningar av 4-(3-fosfono-2-propenyl)-2- piperazinkarboxylsyra
US2935448A (en) Phosphatide therapeutic composition and method of treatment therewith
JPS6117574A (ja) カルシウム拮抗活性のある１‐〔ビス‐（４‐ルオロフエニル）‐メチル〕‐４‐（３‐フエニル‐２‐プロペニル）‐ヘキサヒドロ‐１ｈ‐１，４‐ジアゼピンとその製法及びそれを含有する医薬組成物
JPS5829708A (ja) 痙「れん」
CA1314226C (en) Anti-dementia agent
KR102322349B1 (ko) 척수 손상 또는 척추관 협착증의 예방 또는 치료용 약제학적 조성물
DE3308004A1 (de) Verwendung von dibenzocycloheptenyliden-verbindungen zur modulation der immunreaktion
US3885045A (en) Therapeutic composition containing 1-(2-hydroxy-2-indanyl)-propylamine
DE4436127A1 (de) Verwendung von aromatischen Amiden und Säuren zur Behandlung von rheumatischen Erkrankungen
Evans et al. Chlormethiazole, sleep, and drug withdrawal
WO1994002124A1 (fr) Agent anti-hiv
KR20190090271A (ko) 알레르기비염 완화, 치료 또는 예방용 약학조성물
JP2019006717A (ja) 経口睡眠改善剤
JP3007097B2 (ja) 睡眠薬組成物
Khaunina Neurotropic activity of phenylpyrrolidone-2 isomers
Underwood Drug Sensitivity Presenting as Penile Herpes

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8900834-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8900834-6

Format of ref document f/p: F